10 Worst Performing Biotech Stocks in 2024 - Insider Monkey

Nov 21, 2024 · Here is our list of the 10 worst-performing biotech stocks in 2024. ... As of Q3 2024, 14 hedge funds in the Insider Monkey database held shares in Genmab (NASDAQ:GMAB).

$43
OFF

Why Is Genmab A/S (GMAB) Among The Worst Performing Biotech …

2 weeks from now

The largest stakeholder in the stock was Renaissance Technologies with stakes worth over $43.5 million. Overall GMAB ranks 7th on our list of the worst performing biotech stocks in 2024. …

msn.com

8%
OFF

10 Worst Performing Biotech Stocks In 2024 - Insider Monkey

2 weeks from now

Nov 21, 2024 · Legend Biotech reported strong earnings in the third quarter of 2024, with total revenue reaching $160.2 million, a 66.8% increase from the same period last year.

insidermonkey.com

$2
OFF

10 Worst Performing Biotech Stocks In 2024 - Insider Monkey

2 weeks from now

Nov 21, 2024 · In Q2 2024, BridgeBio Pharma, Inc. (NASDAQ:BBIO) reported revenue of $2.2 million, a slight increase from $1.6 million in Q2 2023. While this revenue growth is minimal, …

insidermonkey.com

7%
OFF

Why These 24 Stocks Are Skyrocketing - Insider Monkey

2 weeks from now

2 days ago · Worst Performing; Other Institutional Investors ... SMFG’s stock price grew by 14.7% in Q4 2024, going from $12.63 on September 30 to $14.49 on December 31, 2024. ... AI Fire …

insidermonkey.com

$9
OFF

11 Stocks That Will Go To The Moon According To Reddit

2 weeks from now

1 day ago · In the third quarter of 2024, enCore Energy Corp. (NASDAQ:EU) generated $9.2 million in revenue, underscoring investor optimism surrounding the stock and its position.

insidermonkey.com

55%
OFF

14 Best 52-Week High Stocks To Buy According To Analysts

2 weeks from now

1 day ago · It was one of the best-performing energy stocks rallying by 55% in 2024 even as the overall sector came under pressure with oil prices plunging below $70 a barrel. ... After rallying …

insidermonkey.com

128%
OFF

Why These 24 Stocks Are Skyrocketing - Insider Monkey

2 weeks from now

3 days ago · Worst Performing; Other Institutional Investors; ... closing Q4 2024 with a stock price of $10.79, registering a 128% jump from its $4.74 close on September 30, 2024. ... Insider …

insidermonkey.com

$13
OFF

Here’s Why Archer Aviation Inc. (ACHR) Is Skyrocketing

2 weeks from now

2 days ago · On December 18, 2024, Analyst firm Cantor Fitzgerald increased its price target for ACHR to $13 from $10. Similarly, Street’s median price target of $11 pointed to an upside of …

insidermonkey.com

FAQs about 10 Worst Performing Biotech Stocks in 2024 - Insider Monkey Coupon?

What happened to biotech stocks in 2023?

As Big Pharma started investing in acquisitions, investor interest increased in late 2023 and early 2024. But the enthusiasm faded, and for months, biotech stocks did not move. Few M&A transactions and initial public offerings (IPOs) broke the otherwise quiet period in the second quarter, which saw a steep fall in biopharma deal activity. ...

Is mRNA a good Biotech stock to buy in 2024?

Overall MRNA ranks 1st on our list of the worst performing biotech stocks in 2024. While we acknowledge the potential of MRNA as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. ...

Is CytK a good Biotech stock to buy?

The largest stakeholder in the company for that quarter was Polar Capital with stakes worth over $124 million. Despite Street analysts' consensus Buy rating on CYTK, it is one of the worst performing biotech stocks on our list with a year-to-date decline of nearly 35%. ...

Will 2024 be a good year for Biotechnology?

Contrary to Holz's perspective, 2024 has started off strongly for the biotechnology sector due to a rise in mergers and acquisitions as well as anticipations of falling interest rates. ...

Is mdgl a good Biotech stock to buy?

Additionally, a trailing return on equity of -106.27% raises concerns about the efficient use of shareholder equity. Overall MDGL ranks 10th on our list of the worst performing biotech stocks in 2024. ...

Why are biotech stocks so volatile?

Biotechnology stocks are among the most volatile in the market due to their high risk. The outcomes of FDA clinical trials and the effectiveness of their therapies in the real world might cause significant fluctuations in their pricing. The introduction of COVID-19 vaccinations in 2020 caused the biotech industry to soar to prominence. ...